This stock comparison between ADEA and EVH examines their relative performance, business models, and market positioning in the current environment. Investors seeking exposure to technology intellectual property (IP) licensing may favor ADEA, while those interested in healthcare services value-based care platforms might eye EVH. Traders analyzing momentum, profitability, and sector trends will find insights into recent earnings beats, guidance, and analyst sentiment. With divergent year-to-date returns and financial profiles, this analysis aids decisions on relative performance and potential trade-offs in a volatile market.
Adeia Inc. (ADEA) operates as a media and semiconductor IP licensing platform, monetizing patent portfolios for multichannel video distributors, over-the-top services, consumer electronics, chipmakers, and social media firms. Headquartered in San Jose, California, the company focuses on stable royalty streams from essential technologies.
In recent market activity, ADEA shares have shown resilience, with year-to-date gains exceeding 64% and one-year returns over 131%, outpacing the S&P 500. The stock recently hit a 52-week high near $34 amid Q1 2026 results that surpassed estimates: revenue of $104.77 million (up from $87.67 million year-ago) and adjusted EPS of $0.38 versus $0.36 expected. Key catalysts include a multi-year license with L’Oréal, an S&P credit rating upgrade, and $58 million in operating cash flow, supporting debt reduction. Sentiment remains positive with a Strong Buy consensus and $33 average target, though CEO Paul Davis plans to step down by Q4 2026, prompting a board search.
Evolent Health, Inc. (EVH) provides specialty care management services in oncology, cardiology, and musculoskeletal areas via an integrated value-based care platform. Based in Arlington, Virginia, it offers administrative tools, analytics, and AI-driven prior authorization via Identifi and Machinify Auth Intelligence for health plans and providers.
Recent weeks have seen volatile trading for EVH, with YTD performance near flat at 0.25% and one-year gains of about 63%, but shares languish near 52-week lows around $4 from a high of $12. Q4 2025 revenue came in at $468.7 million, meeting expectations despite a 27.5% year-over-year drop post-ACO divestiture, with adjusted EBITDA of $37.8 million. Guidance for 2026 projects $2.4–$2.6 billion in revenue and $110–$140 million adjusted EBITDA. High debt of $989.7 million versus $151.9 million cash weighs on sentiment, alongside analyst price target reductions to an average $5.18. Upcoming Q1 results on May 7, 2026, could influence momentum amid medical cost pressures.
Tickeron’s Trending AI Robots page showcases the platform’s top-performing AI trading bots, curated from hundreds of bots trading thousands of tickers across diverse strategies, timeframes, and sectors. Only the most suitable for prevailing market conditions—identified via AI analysis of performance metrics—earn a spot among the 25 featured trending robots out of 351 total. These bots display impressive stats, including annualized returns up to +162%, win rates ranging 51–88%, and profit factors from 1.5 to 11.7, focusing on high-growth areas like semiconductors, AI infrastructure, space tech, and gold miners. Each employs unique styles such as momentum rotation or volatility plays, with real-time signals and risk management. Explore these bots to potentially enhance your trading edge in today’s dynamic markets.
ADEA and EVH diverge sharply in business models: ADEA’s asset-light IP licensing yields high margins (~60% adjusted EBITDA) and predictable royalties, contrasting EVH’s services model exposed to healthcare reimbursement risks and medical loss ratios.
Growth drivers differ: ADEA benefits from tech demand in semiconductors and media, with recent licensing wins; EVH eyes value-based care expansion but faces execution hurdles post-divestiture. Recent momentum strongly favors ADEA (YTD +64% vs. flat), bolstered by profitability (TTM revenue $443M, net income $111M) over EVH’s losses (revenue $1.88B, negative EPS).
Risk factors include ADEA’s CEO transition and litigation exposure versus EVH’s elevated leverage (debt/equity high) and regulatory pressures in healthcare. Sector-wise, tech stability trumps healthcare volatility, with market sentiment leaning toward ADEA’s Strong Buy rating over EVH’s mixed outlook.
Tickeron’s AI currently favors ADEA due to superior trend consistency, profitability, lower relative debt, and stronger recent catalysts like earnings beats and licensing momentum. While EVH offers growth potential in healthcare via 2026 guidance, its instability and negative earnings profile suggest higher risk. Observable factors position ADEA for probable outperformance in the near term, though both warrant monitoring for sector shifts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADEA’s FA Score shows that 3 FA rating(s) are green whileEVH’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADEA’s TA Score shows that 4 TA indicator(s) are bullish while EVH’s TA Score has 6 bullish TA indicator(s).
ADEA (@Packaged Software) experienced а +12.06% price change this week, while EVH (@Services to the Health Industry) price change was +6.39% for the same time period.
The average weekly price growth across all stocks in the @Packaged Software industry was -3.28%. For the same industry, the average monthly price growth was +12.08%, and the average quarterly price growth was +77.76%.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was -0.26%. For the same industry, the average monthly price growth was +26.50%, and the average quarterly price growth was +6.28%.
ADEA is expected to report earnings on Aug 11, 2026.
EVH is expected to report earnings on Aug 05, 2026.
Packaged software comprises multiple software programs bundled together and sold as a group. For example, Microsoft Office includes multiple applications such as Excel, Word, and PowerPoint. In some cases, buying a bundled product is cheaper than purchasing each item individually[s20] . Microsoft Corporation, Oracle Corp. and Adobe are some major American packaged software makers.
@Services to the Health Industry (-0.26% weekly)This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
| ADEA | EVH | ADEA / EVH | |
| Capitalization | 3.44B | 468M | 735% |
| EBITDA | 254M | -319.91M | -79% |
| Gain YTD | 81.151 | 4.000 | 2,029% |
| P/E Ratio | 28.61 | N/A | - |
| Revenue | 460M | 1.89B | 24% |
| Total Cash | 116M | 142M | 82% |
| Total Debt | 400M | 985M | 41% |
ADEA | EVH | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 25 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 25 Undervalued | 65 Fair valued | |
PROFIT vs RISK RATING 1..100 | 8 | 100 | |
SMR RATING 1..100 | 39 | 98 | |
PRICE GROWTH RATING 1..100 | 36 | 40 | |
P/E GROWTH RATING 1..100 | 22 | 15 | |
SEASONALITY SCORE 1..100 | 85 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ADEA's Valuation (25) in the null industry is somewhat better than the same rating for EVH (65) in the Miscellaneous Commercial Services industry. This means that ADEA’s stock grew somewhat faster than EVH’s over the last 12 months.
ADEA's Profit vs Risk Rating (8) in the null industry is significantly better than the same rating for EVH (100) in the Miscellaneous Commercial Services industry. This means that ADEA’s stock grew significantly faster than EVH’s over the last 12 months.
ADEA's SMR Rating (39) in the null industry is somewhat better than the same rating for EVH (98) in the Miscellaneous Commercial Services industry. This means that ADEA’s stock grew somewhat faster than EVH’s over the last 12 months.
ADEA's Price Growth Rating (36) in the null industry is in the same range as EVH (40) in the Miscellaneous Commercial Services industry. This means that ADEA’s stock grew similarly to EVH’s over the last 12 months.
EVH's P/E Growth Rating (15) in the Miscellaneous Commercial Services industry is in the same range as ADEA (22) in the null industry. This means that EVH’s stock grew similarly to ADEA’s over the last 12 months.
| ADEA | EVH | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 77% | 2 days ago 84% |
| Stochastic ODDS (%) | 1 day ago 79% | 2 days ago 79% |
| Momentum ODDS (%) | 1 day ago 77% | 2 days ago 84% |
| MACD ODDS (%) | 1 day ago 65% | 6 days ago 79% |
| TrendWeek ODDS (%) | 1 day ago 73% | 2 days ago 79% |
| TrendMonth ODDS (%) | 1 day ago 71% | 2 days ago 70% |
| Advances ODDS (%) | 2 days ago 71% | 14 days ago 73% |
| Declines ODDS (%) | about 1 month ago 70% | 2 days ago 79% |
| BollingerBands ODDS (%) | 1 day ago 73% | 2 days ago 78% |
| Aroon ODDS (%) | 1 day ago 68% | 2 days ago 64% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VCRIX | 16.19 | 0.02 | +0.12% |
| NYLI CBRE Global Infrastructure Class I | |||
| LAFGX | 21.17 | N/A | N/A |
| Lord Abbett International Growth F | |||
| PMYYX | 52.21 | -0.01 | -0.02% |
| Putnam Core Equity Fund Y | |||
| AILCX | 17.71 | -0.13 | -0.73% |
| American Beacon International Eq C | |||
| ASQCX | 17.77 | -0.23 | -1.28% |
| American Century Small Company C | |||
A.I.dvisor indicates that over the last year, EVH has been loosely correlated with AKAM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if EVH jumps, then AKAM could also see price increases.
| Ticker / NAME | Correlation To EVH | 1D Price Change % | ||
|---|---|---|---|---|
| EVH | 100% | +5.05% | ||
| AKAM - EVH | 46% Loosely correlated | -2.25% | ||
| ADEA - EVH | 44% Loosely correlated | -2.07% | ||
| PRVA - EVH | 40% Loosely correlated | +1.12% | ||
| RIOT - EVH | 39% Loosely correlated | -3.28% | ||
| COIN - EVH | 37% Loosely correlated | -4.14% | ||
More | ||||